Concerns exist about GLP-1 receptor agonists causing substantial weight loss and increasing the risk of ketoacidosis or hypoglycemia, Hui Shao , M D, PhD , associate professor in the Hubert department of global health and Emory Global Diabetes Research Center at Emory University Rollins School of Public Health, and colleagues wrote
The reconstitution process, storage requirements, and injection techniques remain identical regardless of vial size
Additionally, patients with diabetes using these medications alongside insulin or sulfonylureas face increased hypoglycemia risk, which could precipitate seizures in severe cases
Lose too much muscle, and your metabolism tanks
Most studies have found that the drugs fight the urge to drink more in the same way that they help slash food cravings
If you are starting Mounjaro or tirzepatide, here is what the actual clinical literature says about week one